Latest Breaking News On - Julie khlevner - Page 1 : comparemela.com

Ironwood Late-Breaker Oral Presentation at Digestive Disease Week® Reinforces Potential of Once-Weekly Apraglutide for Adults with Short Bowel Syndrome with Intestinal Failure (SBS-IF)

Ironwood Late-Breaker Oral Presentation at Digestive Disease Week® Reinforces Potential of Once-Weekly Apraglutide for Adults with Short Bowel Syndrome with Intestinal Failure (SBS-IF)
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

United statesLin changRegion flamandeNew yorkJulie khlevnerChristopherv almarioKishorer iyerGerard greigLos angelesAstrid verbiestCenter trialUniversity of leuvenCedars sinai medical centerExchange commissionDrug administrationTranslational research center

Gastroenterology Month in Review: January 2024

Our January 2024 Month in Review spotlights the FDA approval of a new indication of dupilumab (Dupixent) for pediatric eosinophilic esophagitis, new clinical trial data, and research about the prevention and management of IBD.

Evan dellonDupilumab dupixentJulie khlevnerDrug administrationUniversity of north carolina chapel hillContemporary pediatricEsophageal diseasesNorth carolina chapel hillPediatric gastrointestinal motility centerColumbia university medical centerInflammatory bowel diseaseEosinophilic esophagitisUlcerative colitis

Julie Khlevner, MD: Linaclotide for Pediatric Functional Constipation

We sat down with Julie Khlevner, MD, to discuss new efficacy endpoint data from the phase 3 study used to support the FDA approval of linaclotide for pediatric functional constipation.

Julie khlevnerDrug administrationLancet gastroenterologyPediatric gastrointestinal motility centerColumbia university medical centerBristol stool form scaleReinforces safetyPediatric functionalFunctional constipationIrritable bowel syndromeSpontaneous bowel movement

Ironwood to Present New Data at Digestive Disease Week® 2023 Demonstrating Potential of Linaclotide for Functional Constipation in Children and Adolescents Ages 6-17 Years-Old

– Pivotal Phase III data will be spotlighted via an oral presentation – – Additional efficacy and safety data will be featured across four posters – . | June 18, 2023

United statesNew yorkHong kongUniversity of miamiTime toJeffrey samuel hyamsAstra zenecaJulie khlevnerSamuel nurkoConnecticut children medical centerIronwood pharmaceuticalsDrug administrationIronwood pharmaceuticals incIronwood pharmaceuticals nasdaqJerome foundationDisease week